News & Updates

Show Multimedia Only

Is long-acting cabotegravir safe as PrEP for expecting mothers?

20 Aug 2024 by

The use of long-acting injectable cabotegravir (CAB-LA) as a pre-exposure prophylaxis (PrEP) during pregnancy appears to be safe and well tolerated in cisgender women, according to the initial data of HPTN* 084 open-label extension (OLE) study presented at AIDS 2024.

Is long-acting cabotegravir safe as PrEP for expecting mothers?

20 Aug 2024

Dual-indication bivalent RSV vaccine now available in HK: Maternal immunization data

20 Aug 2024

Respiratory syncytial virus (RSV) prefusion F protein–based (RSVpreF) vaccine, a single-dose bivalent vaccine against RSV A and RSV B, is now available in Hong Kong for prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth up to 6 months of age through active immunization of pregnant individuals at a gestational age of 32–36 weeks, and for prevention of LRTD caused by RSV in individuals aged ≥60 years.

Dual-indication bivalent RSV vaccine now available in HK: Maternal immunization data

20 Aug 2024

Bivalent dual-indication RSVpreF vaccine: Data in older individuals

19 Aug 2024

A bivalent respiratory syncytial virus (RSV) prefusion F protein–based (RSVpreF) vaccine is now available in Hong Kong for prevention of lower respiratory tract disease (LRTD) caused by RSV in individuals ≥60 years of age, and for prevention of LRTD and severe LRTD caused by RSV in infants from birth up to 6 months of age through active immunization of pregnant individuals at a gestational age of 32–36 weeks.

Bivalent dual-indication RSVpreF vaccine: Data in older individuals

19 Aug 2024

Multistrain probiotics do not reduce multidrug-resistant organisms in preemies

14 Aug 2024

In preterm infants, the use of multistrain probiotics does not appear to prevent colonization with multidrug-resistant organisms or highly epidemic bacteria (MDRO+), as shown in the phase III PRIMAL* trial.

Multistrain probiotics do not reduce multidrug-resistant organisms in preemies

14 Aug 2024

Education package improves pharmacist knowledge, confidence on HIV management

14 Aug 2024

A pharmacy-specific, foundational HIV management education package can help improve pharmacist knowledge in HIV management and self-reported confidence in managing this specialty area, suggests a recent study.

Education package improves pharmacist knowledge, confidence on HIV management

14 Aug 2024

The next Berlin patient: 7th to join pool of HIV patients achieving sustained remission

13 Aug 2024 by

A new patient achieves sustained HIV remission – the seventh in the world – following stem cell therapy for blood cancer and after stopping antiretroviral therapy (ART), adding to the roster of individuals with HIV who are inching their way towards a potential cure.

The next Berlin patient: 7th to join pool of HIV patients achieving sustained remission

13 Aug 2024

Managing COVID-19 in vulnerable adults

12 Aug 2024 by

Despite the success of COVID-19 vaccines, immunocompromised individuals, older adults and those with comorbidities remain at disproportionately high risk of severe outcomes from COVID-19. This underscores the need for additional preventive measures for these vulnerable populations. At the Advances in Medicine (AIM) 2024 conference, Professor Barnaby Young from the National Centre for Infectious Diseases, Singapore, shared insights on current COVID-19 management practices, including the important role of antivirals, such as remdesivir (Veklury^®, Gilead), in treatment of vulnerable patients.

Managing COVID-19 in vulnerable adults

12 Aug 2024

Zero HIV infections: Lenacapavir fulfils PURPOSE in cis women

12 Aug 2024 by

In the interim analysis of the pivotal phase III PURPOSE 1 trial, twice-yearly subcutaneous lenacapavir, a first-in-class, high-potency HIV-1 capsid inhibitor, shows 100-percent efficacy and superiority to background HIV (bHIV*) incidence and daily oral emtricitabine/tenofovir disoproxil fumarate (F/TDF**) for pre-exposure prophylaxis (PrEP) in HIV-negative cisgender women.

Zero HIV infections: Lenacapavir fulfils PURPOSE in cis women

12 Aug 2024

Score model predicts prognosis in older adults with pneumonia

10 Aug 2024

A new prediction score model identifies older patients with community-onset pneumonia who are nearing the end of life and need advance care planning (ACP) practices, reports a study.

Score model predicts prognosis in older adults with pneumonia

10 Aug 2024

STI rates in high-risk populations curbed with doxycycline PrEP

09 Aug 2024 by

Pre-exposure prophylaxis (PrEP) with the antibiotic doxycycline helps to prevent sexually transmitted infections (STIs) in high-risk populations, including female sex workers and HIV-positive men who have sex with men (MSM), according to two small studies.

STI rates in high-risk populations curbed with doxycycline PrEP

09 Aug 2024

News & Updates

Filter by Specialty:

Specialty:

Is long-acting cabotegravir safe as PrEP for expecting mothers?

Is long-acting cabotegravir safe as PrEP for expecting mothers?

Dual-indication bivalent RSV vaccine now available in HK: Maternal immunization data

Dual-indication bivalent RSV vaccine now available in HK: Maternal immunization data

Bivalent dual-indication RSVpreF vaccine: Data in older individuals

Bivalent dual-indication RSVpreF vaccine: Data in older individuals

Multistrain probiotics do not reduce multidrug-resistant organisms in preemies

Multistrain probiotics do not reduce multidrug-resistant organisms in preemies

Education package improves pharmacist knowledge, confidence on HIV management

Education package improves pharmacist knowledge, confidence on HIV management

The next Berlin patient: 7th to join pool of HIV patients achieving sustained remission

The next Berlin patient: 7th to join pool of HIV patients achieving sustained remission

Managing COVID-19 in vulnerable adults

Managing COVID-19 in vulnerable adults

Zero HIV infections: Lenacapavir fulfils PURPOSE in cis women

Zero HIV infections: Lenacapavir fulfils PURPOSE in cis women

Score model predicts prognosis in older adults with pneumonia

Score model predicts prognosis in older adults with pneumonia

STI rates in high-risk populations curbed with doxycycline PrEP

STI rates in high-risk populations curbed with doxycycline PrEP